Advertisement

Topics

Neurocrine to seek FDA OK for Parkinson's disease therapy

04:56 EST 15 Feb 2018 | SmartBrief

Neurocrine Biosciences plans to submit to the FDA a marketing application for opicapone, which is indicated for Parkinson's d -More

Original Article: Neurocrine to seek FDA OK for Parkinson's disease therapy

NEXT ARTICLE

More From BioPortfolio on "Neurocrine to seek FDA OK for Parkinson's disease therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...